RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines ...Middle East

GAITHERSBURG, Md., March 29, 2022 /PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today that is has secured an approximately US$27 million Series A...

Read More Details
Finally We wish PressBee provided you with enough information of ( RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines )

Also on site :

• Anne Burrell's Husband Looks Somber in First Photo Since Food Network Star's Death
• Trump’s Gulf Arab allies race to avoid all-out war in Iran
• Costco's Sturdy New Bookshelf Is So Stunning, Shoppers are Buying 2 at a Time